MDCO: Medicines Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MDCO: Medicines Company

MDCO 84.90

0.0%

Jan 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (36)	1/13/2003 8:17:25 AM
From: Mike	of 125

Tuck, First ask as many questions as you have in your head. I have been researching MDCO for almost six months. I am by no means an expert but do have access to a wealth of experience. I have been in the cardiology field for over 15 years. I am in hospitals everyday. I have been discussing Angiomax with not only cardiologists but also cardiovascular surgeons. The other contacts that I have are all sorts of staff people in the hospitals,other medical device reps and others in the field of cardiology. MDCO is working on quite a few indications other that angioplasty to expand sales. Below is a short list of the "expanded" indications for Angiomax. This section is for health care professionals only. Low Molecular Weight Heparin (LMWH) Pre-treatment Study PK/PD Study Ticlopidine Interaction Study Hirulog® (now ANGIOMAX®) Early Reperfusion/Occlusion (HERO-2) Trial Comparison of Abciximab Complications with Hirulog (now ANGIOMAX®) Ischemic Events Trial (CACHET) Phase A CACHET Phase B CACHET Phase C Anticoagulant Therapy with Bivalirudin to Assist in PCI (ATBAT) 1st Inning Trial (PCI in HIT/HITTS) Drug Interaction Study — ANGIOMAX® plus Integrilin vs. heparin plus Integrilin in PCI Drug Interaction Study — ANGIOMAX® plus Aggrastat vs. heparin plus Aggrastat in PCI REPLACE Study — ANGIOMAX® in the modern PCI setting CABG Off-Pump Study — ANGIOMAX® in OPCAB Graft Surgery For information regarding clinical activities contact angiomax@themedco.com For Angiomax® Medical Information Requests (health care professionals only) call 1-800-ANGIOMAX (1-800-264-4662). Home Copyright © 2002 The Medicines Company. All rights The entire lists is on the companies web site below. themedicinescompany.com I am very interested in this company as it's profile and current clinical activities have been "homeruns". The stock price does not reflect the opportunity that is ahead of it for '03. By having this discussion I am trying to find the "holes" out there that should be evaluated. The problem I have been having is I cant find many. There is risk. But the cost/benefit/risk profile I think is low for having a great stock for "03. If it saves you time dont hesistate to posting all your questions. This way we can decipher if I am married to this investment or we should all look further. Good investing, Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next